Key result
Serum ApoA1 levels were significantly lower in patients with atherothrombotic infarction compared to age-matched controls (128.6 vs 149.3 mg/dL, p<0.05).
Why the study?
The study aimed to investigate the association between serum apolipoprotein A1 levels, ischemic stroke subtypes, and carotid plaque properties.
Are serum ApoA1 levels associated with specific ischemic stroke subtypes and carotid plaque properties?
Cross-Sectional (n=113)
No
Are serum ApoA1 levels associated with specific ischemic stroke subtypes and carotid plaque properties?
Absolute Event Rate: 128.6% vs 149.3%
p-value: p=<0.05
Lower serum ApoA1 levels are associated with atherothrombotic stroke and more vulnerable (low-intensity and mixed) carotid plaque characteristics.
May inform atherothrombotic stroke subtyping; leaves open whether ApoA1 improves risk prediction or warrants prospective validation.
BACKGROUND: This study aimed to investigate the association between serum apolipoprotein A1 (ApoA1) levels, ischemic stroke subtypes and plaque properties. METHODS: We enrolled 92 patients with ischemic stroke and 21 age-matched controls (CONT). The stroke patients were divided into three subtypes: cardioembolic (CE, n = 15), atherothrombotic infraction (ATBI, n = 52), and lacunar infarction (LI, n = 25). Carotid plaques were classified as low, intermediate, or high intensity, and either simple or mixed type. Serum lipids (total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglyceride (TG)), ApoA1, and ApoB were analyzed using commercially available kits. RESULTS: There was no difference in TC, LDL-C, HDL-C, and ApoB levels among the four groups. Serum ApoA1 levels in the ATBI group were significantly lower compared with the CONT group. Among the ATBI group, the serum ApoA1 levels in the low-intensity plaque-type were significantly lower than those in the intermediate or hard-intensity plaque-type. Furthermore, serum ApoA1 levels in the mixed plaque-type were significantly lower than those in the simple type. CONCLUSIONS: These findings suggest that serum ApoA1 levels might be associated with the development of ATBI and plaque properties of the carotid artery.
No takes yet. Share an insight, caveat, or question.
Ohtani et al. (2020) conducted a cross-sectional in Ischemic stroke (n=113). Serum Apolipoprotein A1 (ApoA1) vs. Age-matched controls was evaluated on Serum ApoA1 levels (mg/dL) (p=<0.05). Serum ApoA1 levels were significantly lower in patients with atherothrombotic infarction compared to age-matched controls (128.6 vs 149.3 mg/dL, p<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: